We evaluated the mutation spectrum and features of 186 lung cancer specimens with no mutations/translocations in EGFR or ALK. Our results showed significant differences in the distribution of sex, age, and smoking status of these patients compared with those with EGFR positive mutation or ALK fusion. This evidence concerns the gene EGFR and lung cancer.